Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit
17 września 2020 zaktualizowane przez: University of Wisconsin, Madison
Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach; Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit
The ultimate goal of this research is to develop a chronic care treatment package for smokers that will address the challenges and opportunities of each phase of the cessation process - motivation, preparation, cessation, maintenance, and relapse recovery.
That is, to develop treatments for smokers not yet ready to quit, those who are preparing to quit, those actively engaged in the quitting process and those who have tried to quit but relapsed.
To achieve this goal, this research comprises three distinct research studies, each of which represent a phase in a comprehensive chronic care treatment model for clinical intervention with smokers in the primary care setting: the Motivation Study, the Cessation Study, and the Long-term Quitting Study.
The goal of each study is to test and identify effective intervention components for distinct phases of the smoking cessation process.
These components will then be combined for future research on the effectiveness of this chronic care treatment package.
This study is a 2x2x2x2 factorial design.
Participants will be randomized to one of two levels on four different factors: 1) Nicotine Mini-Lozenge vs.
No Mini-Lozenge, 2) Behavioral Reduction Counseling (intervention: BR) vs.
No Behavioral Reduction Counseling, 3) 5Rs Motivation Counseling (intervention 5 R's) vs.
No 5Rs Motivation Counseling, and 4) Behavioral Activation Counseling (intervention BA) vs.
No Behavioral Activation Counseling.
These components have strong theoretical and empirical support, but their relative, additive, and interactive effects are unknown.
Przegląd badań
Status
Zakończony
Warunki
Typ studiów
Interwencyjne
Zapisy (Rzeczywisty)
577
Faza
- Faza 4
Kontakty i lokalizacje
Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.
Lokalizacje studiów
-
-
Wisconsin
-
Madison, Wisconsin, Stany Zjednoczone, 53711-2027
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
-
-
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
18 lat i starsze (Dorosły, Starszy dorosły)
Akceptuje zdrowych ochotników
Nie
Płeć kwalifikująca się do nauki
Wszystko
Opis
Inclusion Criteria:
- age >=18 years; smoking >4 cigarettes/day for the previous 6 months; able to read, write, and speak English; have reliable phone access and agree to respond to Interactive Voice Response (IVR) phone prompts; and if currently using NRT, agreeing to use only study medication for the duration of the study. We will not exclude participants based on their prior use of cessation medication or if they use multiple tobacco products in order to enhance real-world generalization (these will be statistically controlled in analyses); not currently attempting to quit smoking; not intending to quit smoking (defined as no plans to quit in the next month); and planning to remain in the intervention catchment area for at least 12 months.
Exclusion Criteria:
- currently taking bupropion or varenicline; medical contraindications to using NRT including hospitalized (for at least one night) for a stroke, heart attack, congestive heart failure or diabetes in the last 30 days; diagnosis of or treatment for schizophrenia, a psychotic disorder or bipolar disorder in the last 10 years; and, if the participant is a woman of childbearing potential, being pregnant or intending to becoming pregnant or unwillingness to use an approved method of birth control during treatment.
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przypisanie czynnikowe
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Mini-Lozenge, BR, 5Rs, BA
1; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: Mini-Lozenge, BR, 5Rs, No BA
2; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Eksperymentalny: Mini-Lozenge, BR, No 5Rs, BA
3; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, No 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: Mini-Lozenge, BR, No 5Rs, No BA
4; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, BR, No 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
|
|
Eksperymentalny: Mini-Lozenge, No BR, 5Rs, BA
5; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: Mini-Lozenge, No BR, 5Rs, No BA
6; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Eksperymentalny: Mini-Lozenge, No BR, No 5Rs, BA
7; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, No 5Rs, BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: Mini-Lozenge, No BR, No 5Rs, No BA
8; This arm of the project will address the following question: How effective is the following intervention?
Mini-Lozenge, No BR, No 5Rs, No BA
|
If randomized to only the Nicotine Mini-Lozenge condition: Participants randomized to this condition will receive up to a 12 month supply of 2 mg or 4 mg nicotine mini-lozenges.
Mini-Lozenges will be given at the initial visit and over the course of the whole study.
Participants will be instructed to use 9 pieces daily for the 12 months.
|
|
Eksperymentalny: No Mini-Lozenge, BR, 5Rs, BA
9; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, 5Rs, BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: No Mini-Lozenge, BR, 5Rs, No BA
10; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, 5Rs, No BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Eksperymentalny: No Mini-Lozenge, BR, No 5Rs, BA
11; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, No 5Rs, BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: No Mini-Lozenge, BR, No 5Rs, No BA
12; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, BR, No 5Rs, No BA
|
We will deliver BR in 10 (10-15 minute) sessions over a 52-week period, with an in-person session at Visit 1 followed by nine phone counseling sessions.
Sessions are front-loaded to enhance acquisition of new behaviors.
BR Counseling will emphasize the development of smoking control skills via feasible, specific, and graded assignments of smoking reduction activities that will be tracked over time.
BR will also emphasize competence and self-efficacy, both which will be directly linked to the practice of smoking reduction skills and success in smoking control.
The health counselor will provide rationales for the reduction intervention, why reduction (e.g., eliminating smoking contexts) should help the smoker, and provide the participant with specific exercises and goals.
The health counselor will explicitly address pragmatic issues such as work contexts, smoking policies, and habits that interfere with smoking reduction efforts.
|
|
Eksperymentalny: No Mini-Lozenge, No BR, 5Rs, BA
13; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, 5Rs, BA
|
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: No Mini-Lozenge, No BR, 5Rs, No BA
14; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, 5Rs, No BA
|
The 5Rs Motivation Counseling will be delivered in four (10-15 min) sessions over a 52-week period.
Participants in the "on" condition will receive three brief phone sessions over the year to prompt processing of motives for smoking reduction or cessation.
The health counselor and smoker will discuss: 1) Relevance of smoking to the individual; 2) Risks of continued heavy smoking; 3) Rewards of quitting and significant reduction; and 4) Roadblocks to success; and will do so on a 5) Repeated basis.
The discussion will follow the general principles of MI: counselors will use strategies that are nonauthoritarian, nonconfrontational, supportive, and use open-ended questions.
|
|
Eksperymentalny: No Mini-Lozenge, No BR, No 5Rs, BA
15; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, No 5Rs, BA
|
The BA treatment will be delivered in 10 (10-15 minute) sessions over a 52-week period starting with Visit 1 followed by nine phone counseling sessions.
This BA treatment will be modeled after Behavioral Activation for quitting smoking, but made relevant for smoking reduction.
Treatment goals focus on helping participants engage in positively reinforcing activities while not smoking.
The treatment includes: 1) a rationale for the BA exercises as they relate to smoking (e.g., engaging in non-smoking reinforcers will provide other sources of pleasure and assist with cutting down); 2) assessment of the participant's goals, values, and reinforcing value of current nonsmoking activities; 3) training in self-monitoring using an activity log; 4) ongoing assignments of activities that should significantly increase the participant's nonsmoking reinforcement and create broader lifestyle and cue exposure changes; and 5) problem-solving to address obstacles to goal attainment.
|
|
Eksperymentalny: No Mini-Lozenge, No BR, No 5Rs, No BA
16; This arm of the project will address the following question: How effective is the following intervention?
No Mini-Lozenge, No BR, No 5Rs, No BA
|
Brak leczenia
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
7-Day Point-Prevalence Abstinence
Ramy czasowe: 12 months
|
Participants who self-report no smoking for the past 7 days at the assessment endpoint (12 month follow-up) will be considered to meet criteria for 7-Day Point-Prevalence Abstinence.
Participants who who report any smoking in the past 7 days (at the 12 month follow-up) will be considered to be relapsed (smoking).
|
12 months
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Sponsor
Współpracownicy
Śledczy
- Krzesło do nauki: Michael C Fiore, MD, MPH, MBA, University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
- Dyrektor Studium: Jessica Cook, PhD, University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
- Główny śledczy: Robin Mermelstein, PhD, Institute for Health Research and Policy, University of Illinois at Chicago
Publikacje i pomocne linki
Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
1 stycznia 2015
Zakończenie podstawowe (Rzeczywisty)
19 marca 2019
Ukończenie studiów (Rzeczywisty)
19 marca 2019
Daty rejestracji na studia
Pierwszy przesłany
22 stycznia 2015
Pierwszy przesłany, który spełnia kryteria kontroli jakości
29 stycznia 2015
Pierwszy wysłany (Oszacować)
3 lutego 2015
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
22 września 2020
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
17 września 2020
Ostatnia weryfikacja
1 września 2020
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2014-1041Motivation
- A534252 (Inny identyfikator: UW Madison)
- CTRI (Inny identyfikator: UW Madison)
- SMPH\MEDICINE\TOBACCO RE (Inny identyfikator: UW Madison)
- 1P01CA180945-01 (Grant/umowa NIH USA)
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Nie
Bada produkt urządzenia regulowany przez amerykańską FDA
Nie
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .